Overview
Binay Shah is a Hematologist Oncology provider in Sequim, Washington. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia (AML), Lung Cancer, and WT1-Related Wilms Tumor Syndromes. Dr. Shah is currently accepting new patients.
His clinical research consists of co-authoring 56 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Bladder Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
- PPO
- EPO
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Association Of University Physicians
Andrew Hsieh is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Hsieh is rated as an Advanced provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Prostate Cancer, and Orchiectomy. Dr. Hsieh is currently accepting new patients.
The Association Of University Physicians
Todd Yezefski is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Yezefski is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Urothelial Cancer, and Hormone Replacement Therapy (HRT). Dr. Yezefski is currently accepting new patients.
Virginia Mason Medical Center
John Flores is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Flores has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, WT1-Related Wilms Tumor Syndromes, Prostatectomy, and Splenectomy. Dr. Flores is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloid Leukemia (AML)Dr. Shah isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Shah isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Chronic Lymphocytic Leukemia (CLL)Dr. Shah isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Clear Cell SarcomaDr. Shah isDistinguished. Learn about Clear Cell Sarcoma.
- Lung CancerDr. Shah isDistinguished. Learn about Lung Cancer.
- Myelodysplastic Syndrome (MDS)Dr. Shah isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- ALK-Positive Non-Small Cell Lung Cancer
- AngiosarcomaDr. Shah isAdvanced. Learn about Angiosarcoma.
- B-Cell LymphomaDr. Shah isAdvanced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Shah isAdvanced. Learn about Breast Cancer.
- Chromophobe Renal Cell Carcinoma
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Shah isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Mountain SicknessDr. Shah isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Ampullary CancerDr. Shah isExperienced. Learn about Ampullary Cancer.
- Anal CancerDr. Shah isExperienced. Learn about Anal Cancer.
- Anaplastic Thyroid CancerDr. Shah isExperienced. Learn about Anaplastic Thyroid Cancer.